PAVmed, Inc. (PAVM)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
Oct 09, 16:00
2.79
0.00 (0.00%)
After-Hours: 20:00
PAVmed EPS Diluted (Quarterly) : -0.8739 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8739 |
| March 31, 2026 | -4.421 |
| December 31, 2025 | -2.368 |
| September 30, 2025 | -8.807 |
| June 30, 2025 | -22.08 |
| March 31, 2025 | 0.3371 |
| December 31, 2024 | 3.606 |
| September 30, 2024 | 1.441 |
| June 30, 2024 | -1.192 |
| March 31, 2024 | -2.621 |
| December 31, 2023 | -1.936 |
| September 30, 2023 | -2.378 |
| June 30, 2023 | -2.100 |
| March 31, 2023 | -2.782 |
| December 31, 2022 | -3.259 |
| September 30, 2022 | -4.378 |
| June 30, 2022 | -4.415 |
| March 31, 2022 | -88.29 |
| December 31, 2021 | -3.002 |
| September 30, 2021 | -2.214 |
| June 30, 2021 | -2.106 |
| March 31, 2021 | -1.928 |
| December 31, 2020 | -2.559 |
| Date | Value |
|---|---|
| September 30, 2020 | -1.723 |
| June 30, 2020 | -1.892 |
| March 31, 2020 | -5.016 |
| December 31, 2019 | -2.850 |
| September 30, 2019 | -1.524 |
| June 30, 2019 | -1.989 |
| March 31, 2019 | -1.989 |
| December 31, 2018 | -3.811 |
| September 30, 2018 | -1.872 |
| June 30, 2018 | -3.988 |
| March 31, 2018 | -3.096 |
| December 31, 2017 | 0.3192 |
| September 30, 2017 | -6.00 |
| June 30, 2017 | -35.14 |
| March 31, 2017 | -4.80 |
| December 31, 2016 | -1.95 |
| September 30, 2016 | -2.10 |
| June 30, 2016 | -1.482 |
| March 31, 2016 | -0.7854 |
| December 31, 2015 | -0.8235 |
| September 30, 2015 | -0.601 |
| June 30, 2015 | -0.4022 |
| March 31, 2015 | -0.1632 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.598M |
| Revenue (Quarterly) | 0.033M |
| Total Expenses (Quarterly) | 5.417M |
| Enterprise Value | 18.88M |
| Gross Profit Margin (Quarterly) | -327.3% |
| Profit Margin (Quarterly) | -19.99K% |
| Earnings Yield | -590.3% |
| Normalized Earnings Yield | -465.84 |